BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Cryterion Medical is defunct.

Fate: Boston Scientific acquired remaining 65% stake, July 2018, $202M


------------------
If you believe any of this information is incorrect, please let us know.